文献速递乳腺技术与安全乳腺X线USMRCT

乳腺外恶性肿瘤乳腺转移:播散途径、影像特征与管理策略综述

Metastatic breast involvement from extramammary malignancies: a review of dissemination pathways, imaging features, and management strategies.
PubMed 文献 · Radiol Med · 2025-09-08

本文为叙述性综述,分析乳腺外恶性肿瘤乳腺转移(MB)按血行、淋巴和直接蔓延三种途径的影像表现;血行转移最常见,表现为边界清晰无钙化结节且无腋窝淋巴结受累,淋巴转移呈弥漫水肿和橘皮样改变,直接蔓延见于晚期肺癌;多模态影像结合病史和病理有助于早期诊断并避免不必要手术。

要点

  • 乳腺转移瘤边界清晰、无钙化且无腋窝淋巴结受累时,需与原发性乳腺癌鉴别。
  • 淋巴途径转移可致弥漫性乳腺水肿、皮肤增厚和橘皮样外观,类似炎性乳腺癌。
  • 直接蔓延见于晚期肺癌,表现为自胸壁延伸的浸润性病变。

核心结论

  • 乳腺转移瘤罕见且异质性强,诊断需结合肿瘤病史、影像与病理的多学科方法;识别特定影像模式有助于早期诊断、避免不必要手术并指导基于原发肿瘤的全身治疗。

研究设计与样本

  • 叙述性综述,基于播散途径(血行、淋巴、直接蔓延)分析乳腺外恶性肿瘤乳腺转移病例;未报告系统检索策略、纳入文献数量或证据分级。

关键影像表现/征象

  • 血行转移表现为边界清晰、无钙化的结节,无腋窝淋巴结受累,可与原发性乳腺癌区分。
  • 淋巴转移常见于血行转移性恶性肿瘤,引起弥漫性乳腺水肿、皮肤增厚和橘皮样外观,类似炎性乳腺癌。
  • 直接蔓延较少见,见于晚期肺癌,表现为从胸壁延伸的浸润性病变。

诊断标准与关键数值

  • 乳腺转移瘤占所有乳腺恶性肿瘤的0.09-1.3%。
  • 组织病理学和免疫组化分析确认乳腺外来源。

临床应用与阅片要点

  • 多模态影像(乳腺X线摄影、超声、磁共振、计算机断层扫描和正电子发射断层扫描)对检测乳腺转移至关重要。
  • 诊断需整合肿瘤病史、影像和病理的多学科方法。
  • 识别特定影像模式可能影响临床管理决策并改善患者结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Metastatic involvement (MB) of the breast from extramammary malignancies is rare, with an incidence of 0.09-1.3% of all breast malignancies. Due to its variable clinical and radiological presentation, MB often mimics primary breast cancer (BC), leading to potential misdiagnosis and impacting treatment decisions. This narrative review analysed MB cases based on dissemination pathways: hematogenous (HM), lymphatic (LM), or direct contiguous (DC) spread. HM was the most frequent, particularly in melanoma, lung, renal, and gastrointestinal carcinomas, presenting as well-circumscribed, non-calcified nodules without axillary lymph node involvement, distinguishing them from BC. LM spread, common in HM malignancies, caused diffuse breast oedema, skin thickening, and a "peau d'orange" appearance, resembling inflammatory BC. DC spread, though rarer, was observed in advanced lung cancer, with infiltrative lesions extending from the chest wall. Multimodal imaging (Mammography (DM), Ultrasound (US), Magnetic Resonance Imaging (MRI), Computer Tomography (CT), and Positron Emission Tomography (PET)) was critical for detecting MB, while histopathological and immunohistochemical analysis confirmed extramammary origin. Due to the rarity and heterogeneity of MB, diagnosis requires a multidisciplinary approach integrating oncological history, imaging, and pathology. Recognising distinct imaging patterns can aid early diagnosis, avoid unnecessary surgery, and guide appropriate systemic therapy based on the primary malignancy. Early identification of the metastatic pattern may influence clinical management decisions and improve patient outcomes.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Mariano L, Nicosia L, Latronico A, et al. Metastatic breast involvement from extramammary malignancies: a review of dissemination pathways, imaging features, and management strategies. Radiol Med. 2025. PMID: 40920280. doi:10.1007/s11547-025-02085-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。